Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Mar;159(3):1126-1135.
doi: 10.1016/j.chest.2020.11.026. Epub 2020 Nov 30.

Chest CT in COVID-19 at the ED: Validation of the COVID-19 Reporting and Data System (CO-RADS) and CT Severity Score: A Prospective, Multicenter, Observational Study

Affiliations
Observational Study

Chest CT in COVID-19 at the ED: Validation of the COVID-19 Reporting and Data System (CO-RADS) and CT Severity Score: A Prospective, Multicenter, Observational Study

Arthur W E Lieveld et al. Chest. 2021 Mar.

Abstract

Background: CT is thought to play a key role in coronavirus disease 2019 (COVID-19) diagnostic workup. The possibility of comparing data across different settings depends on the systematic and reproducible manner in which the scans are analyzed and reported. The COVID-19 Reporting and Data System (CO-RADS) and the corresponding CT severity score (CTSS) introduced by the Radiological Society of the Netherlands (NVvR) attempt to do so. However, this system has not been externally validated.

Research question: We aimed to prospectively validate the CO-RADS as a COVID-19 diagnostic tool at the ED and to evaluate whether the CTSS is associated with prognosis.

Study design and methods: We conducted a prospective, observational study in two tertiary centers in The Netherlands, between March 19 and May 28, 2020. We consecutively included 741 adult patients at the ED with suspected COVID-19, who received a chest CT and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) PCR (PCR). Diagnostic accuracy measures were calculated for CO-RADS, using PCR as reference. Logistic regression was performed for CTSS in relation to hospital admission, ICU admission, and 30-day mortality.

Results: Seven hundred forty-one patients were included. We found an area under the curve (AUC) of 0.91 (CI, 0.89-0.94) for CO-RADS using PCR as reference. The optimal CO-RADS cutoff was 4, with a sensitivity of 89.4% (CI, 84.7-93.0) and specificity of 87.2% (CI, 83.9-89.9). We found a significant association between CTSS and hospital admission, ICU admission, and 30-day mortality; adjusted ORs per point increase in CTSS were 1.19 (CI, 1.09-1.28), 1.23 (1.15-1.32), 1.14 (1.07-1.22), respectively. Intraclass correlation coefficients for CO-RADS and CTSS were 0.94 (0.91-0.96) and 0.82 (0.70-0.90).

Interpretation: Our findings support the use of CO-RADS and CTSS in triage, diagnosis, and management decisions for patients presenting with possible COVID-19 at the ED.

Keywords: COVID-19; CT; emergency medicine; pneumonia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study population diagram. CO-RADS = COVID-19 Reporting and Data System; PCR = polymerase chain reaction.
Figure 2
Figure 2
Distribution of PCR results and CO-RADS. CO-RADS = COVID-19 Reporting and Data System; PCR = polymerase chain reaction.
Figure 3
Figure 3
ROC Curve CO-RADS vs PCR results. AUC = area under the curve; CO-RADS = COVID-19 Reporting and Data System; PCR = polymerase chain reaction; ROC = receiver operating characteristic.

Comment in

References

    1. Coronavirus Update (Live)—Worldometers. https://www.worldometers.info/coronavirus/ Accessed February 2, 2021.
    1. Johns Hopkins Coronavirus Resource Center COVID-19 Map. https://coronavirus.jhu.edu/map.html Accessed February 2, 2021.
    1. Sethuraman N, Jeremiah SS, Ryo A. Interpreting diagnostic tests for SARS-CoV-2. JAMA. 323(22):2249-2251. - PubMed
    1. Abbasi J. The promise and peril of antibody testing for COVID-19. JAMA. 2020;323(19):1881–1883. - PubMed
    1. Wang W., Xu Y., Gao R. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843–1844. - PMC - PubMed

MeSH terms